View More Recent Stories

May 18, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 17, 2025 11:51AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 17, 2025 08:40AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
May 15, 2025 05:36PM Zenas BioPharma, Inc. (ZBIO) Reports Q1 Loss of $0.80
May 14, 2025 09:17PM ROSEN, A TOP-RANKED INVESTOR RIGHTS FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 13, 2025 09:12PM ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 13, 2025 08:20PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
May 12, 2025 09:07PM ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 12, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 11, 2025 09:02PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 10, 2025 08:11AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
May 9, 2025 09:14PM ROSEN, A LONGSTANDING FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 8, 2025 08:02PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 7, 2025 07:57PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 6, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 6, 2025 11:23AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
May 5, 2025 03:57PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
May 4, 2025 09:44AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
May 2, 2025 04:58PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 30, 2025 08:35PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
Apr 30, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 30, 2025 03:42PM ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 29, 2025 01:21PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 27, 2025 10:23AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 26, 2025 10:18AM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 24, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 24, 2025 03:20PM ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - ZBIO
Apr 23, 2025 01:55PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 22, 2025 01:00PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
Apr 21, 2025 05:15PM ROSEN, A RANKED AND LEADING FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - ZBIO
Apr 20, 2025 09:17AM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - ZBIO
Apr 18, 2025 09:04PM ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - ZBIO
Apr 18, 2025 04:00PM ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 17, 2025 09:04PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
Apr 7, 2025 07:06AM Zenas BioPharma (ZBIO) Appoints Haley Laken as Chief Scientific Officer
Apr 3, 2025 01:18PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
Mar 30, 2025 11:10PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
Mar 27, 2025 10:23AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
Mar 17, 2025 07:05AM Zenas BioPharma (ZBIO) Appoints Lisa von Moltke as Chief Medical Officer
Dec 16, 2024 06:43AM H.C. Wainwright Starts Zenas Biopharma (ZBIO) at Buy
Dec 12, 2024 06:33AM Guggenheim Reiterates Buy Rating on Zenas Biopharma (ZBIO)
Nov 12, 2024 05:32PM Zenas BioPharma, Inc. (ZBIO) Reports Q3 Loss of $5.02
Oct 8, 2024 04:01AM Citi Starts Zenas Biopharma (ZBIO) at Buy
Oct 8, 2024 03:41AM Morgan Stanley Starts Zenas Biopharma (ZBIO) at Overweight
Oct 8, 2024 02:54AM Guggenheim Starts Zenas Biopharma (ZBIO) at Buy
Oct 8, 2024 02:49AM Jefferies Starts Zenas Biopharma (ZBIO) at Buy
Sep 13, 2024 06:18AM Zenas BioPharma (ZBIO) Prices Upsized 13.24M Share IPO at $17/sh
Sep 6, 2024 06:18AM Zenas BioPharma (ZBIO) Files for 11.76M Share IPO at $16-$18/sh
View More Recent Stories